The Michael J Fox Foundation Translational Biomarker Portfolio & Research Resources Overview
Time: 3:45 pm
day: Conference Day One
Details:
- The Foundation’s biomarker portfolio has historically been largely focused on biochemical assays and spans a number of relevant pathways in Parkinson’s disease, including alpha-synuclein and neuroinflammation
- Challenges around inflammation-based biomarkers for Parkinson’s disease
- The Foundation offers a variety of resources to the research community in addition to funding opportunities: preclinical tools database, access to biospecimens and large datasets for additional analysis, venues for knowledge sharing
